Literature DB >> 10549815

Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area.

E M Nikulina1, R P Hammer, K A Miczek, R M Kream.   

Abstract

Prompted by previous studies linking social defeat stress to changes in opioid antinociception, we evaluated the expression of mu-opioid receptor (MOR)-encoding mRNA in selected rat brain areas as a function of this type of stress. Because opioids mediate significant regulatory activities of brain dopamine neurons, dopaminergic loci in the ventral tegmental area (VTA) and substantia nigra (SN) were selected for analysis. Within 30 min after social defeat stress, the level of MOR-encoding mRNA, as detected and quantified by in situ hybridization histochemistry, increased in the lateral VTA and this increase was present for at least 6 h. In contrast, defeat stress was without effect on the expression of MOR-encoding mRNA in the SN. These data suggest that stress-induced alteration of MOR-encoding mRNA expression in the VTA may be involved in the consequences of social defeat stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549815     DOI: 10.1097/00001756-199909290-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  Repeated restraint stress alters sensitivity to the social consequences of ethanol in adolescent and adult rats.

Authors:  Elena I Varlinskaya; Tamara L Doremus-Fitzwater; Linda P Spear
Journal:  Pharmacol Biochem Behav       Date:  2010-05-15       Impact factor: 3.533

2.  Next generation effects of female adolescent morphine exposure: sex-specific alterations in response to acute morphine emerge before puberty.

Authors:  Fair M Vassoler; Nicole L Johnson-Collins; Lindsay M Carini; Elizabeth M Byrnes
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

3.  Neurochemically distinct circuitry regulates locus coeruleus activity during female social stress depending on coping style.

Authors:  Beverly A S Reyes; Xiao-Yan Zhang; Elsa C Dufourt; Seema Bhatnagar; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2019-02-14       Impact factor: 3.270

Review 4.  Modulation of nociception by social factors in rodents: contribution of the opioid system.

Authors:  Francesca R D'Amato; Flaminia Pavone
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

5.  Downregulation of serotonergic gene expression in the Raphe nuclei of the midbrain under chronic social defeat stress in male mice.

Authors:  Ul'yana A Boyarskikh; Natalya P Bondar; Maxim L Filipenko; Natalia N Kudryavtseva
Journal:  Mol Neurobiol       Date:  2013-02-08       Impact factor: 5.590

6.  Decreased response to social defeat stress in μ-opioid-receptor knockout mice.

Authors:  Hiroshi Komatsu; Arihisa Ohara; Kazumasu Sasaki; Hiromi Abe; Hisaki Hattori; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Pharmacol Biochem Behav       Date:  2011-06-15       Impact factor: 3.533

Review 7.  Gene expression in aminergic and peptidergic cells during aggression and defeat: relevance to violence, depression and drug abuse.

Authors:  Klaus A Miczek; Ella M Nikulina; Aki Takahashi; Herbert E Covington; Jasmine J Yap; Christopher O Boyson; Akiko Shimamoto; Rosa M M de Almeida
Journal:  Behav Genet       Date:  2011-03-17       Impact factor: 2.805

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 9.  Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake.

Authors:  Klaus A Miczek; Jasmine J Yap; Herbert E Covington
Journal:  Pharmacol Ther       Date:  2008-08-15       Impact factor: 12.310

10.  Long-lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of mu-opioid receptor mRNA and FosB/DeltaFosB immunoreactivity.

Authors:  Ella M Nikulina; Isabel Arrillaga-Romany; Klaus A Miczek; Ronald P Hammer
Journal:  Eur J Neurosci       Date:  2008-05       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.